A QUEBEC COMPANY
FOUNDED BY A PHARMACIST

Home > News

What's new in RxVigilance

The various calculation tools and drug administration schedules developed by RxVigilance have been revamped. All the features however, remain the same. You can access the various documents via the Calculation Tools index and the Drug Schedules tool from the bottom of the homepage.

Changes have been made to the layout in the Warnings section of the monographs of drugs associated with QT interval prolongation. The risk factors are no longer itemized one by one. Instead, there is but a statement warning of QT interval prolongation. Alerts related to the various risk factors however, will still be generated, and you may also consult the entire list in our document entitled Drugs that can prolong the QT interval.

A comprehensive review of the document on drug-induced serotonin toxicity (also known as serotonin syndrome) has been completed.A patient handout on the causes, symptoms and prevention of serotonin toxicity has also been added.

Four algorithms have been integrated into our software. They are aimed at health care professionals interested in deprescribing certain classes of drugs. The following algorithms are now available: Proton Pump Inhibitors, Antipsychotics, Antihyperglycemics and Benzodiazepines & Z-Drugs. The documents were created by a Canadian Pharmacist and a Physician, Clinicians and Researchers, who developed the website deprescribing.org.

The 2017 Hypertension Canada Guidelines for the Management of Hypertension and the What?s New in 2017? overview are now available in the Professional Documentation section.

DISCOVER

OUR PRODUCTS

A software package that provides information on drugs, health products and disease.
Learn more
Our reference tool for health care professionals that features information on drugs and health, now accessible from anywhere.
Learn more

OUR TOOLS WHICH HAVE NOW BECOME INDISPENSABLE

AIM TO ENSURE THE SAFE AND OPTIMAL USE OF DRUGS

Our partners